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Abstract 
Interpreting molecular profiles in a biological context requires specialized analysis strategies. Initially, lists of relevant 
genes were screened to identify enriched concepts associated with pathways or specific molecular processes. How-
ever, the shortcoming of interpreting gene lists by using predefined sets of genes has resulted in the development 
of novel methods that heavily rely on network-based concepts. These algorithms have the advantage that they allow 
a more holistic view of the signaling properties of the condition under study as well as that they are suitable for inte-
grating different data types like gene expression, gene mutation, and even histological parameters.
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For many researchers worldwide, unravelling the biol-
ogy of human tumors, either primary or metastatic, is 
a daily practice. The development of high-throughput 
technologies, such as microarrays and next-generation 
sequencing, has greatly accelerated our understanding of 
the complex molecular underpinnings of cancer devel-
opment and progression. Big sequencing consortia like 
The Cancer Genome Atlas and the International Cancer 
Genome Consortium provide the research community 
with an unprecedented wealth of genomic, epigenomic, 
transcriptomic, and proteomic details of various tumor 
and cell types [1–8]. The recent landscape of published 
articles represents only the initial analyses, and answers 
to many other important questions may well be buried 
deep inside the reported data.
Many cancer profiling experiments have the common 
goal of identifying the signal transduction pathways and 
processes that characterize tumor biology, with the ulti-
mate aim of discovering novel targets for treatment. The 
current mass production of molecular cancer profiles 
has spurred the development of novel tools particularly 
designed for this purpose. Most of these tools build on 
the concept of gene set enrichment analysis (GSEA), 
which evaluates whether the overlap between two gene 
sets is greater than that expected by chance [9]. Ana-
lyzed gene sets represent lists of significantly mutated or 
overexpressed genes on the one hand and lists of gene-
associated pathways or processes on the other hand. 
The latter are based on prior knowledge gained through 
decades of basic and translational research and can be 
found in various publically available databases, such as 
the Gene Ontology, the Kyoto Encyclopedia of Genes and 
Genomes, and the Biocarta.
However, novel biological insights have increas-
ingly called into question the classical representation of 
processes and particularly pathways as hierarchically 
structured as well as mostly linear diagrams of protein–
protein interactions that are sharply and precisely delin-
eated from the broader cellular transduction network. 
Instead, the now-prevailing understanding of systems 
biologists is to think of pathways and processes as warm 
and fuzzy clouds: warm since their representation is 
close to the truth but not necessarily exact; fuzzy since 
the membership of components in a pathway is graded 
and dynamic, and therefore not all components of a 
pathway are equally important and might vary; and a 
cloud since the boundaries of a pathway are not sharply 
defined because, among other reasons, many of the path-
ways and processes connect to form a network [10]. This 
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new definition has inspired the development of novel 
algorithms that incorporate network statistics to derive 
biological knowledge from molecular profiles. Two 
important steps can be discerned: (1) network inference, 
which is the process of building networks from molecu-
lar data [11], and (2) network enrichment analysis, which 
incorporates topological information present in the net-
work to identify which pathways and processes are rel-
evant and how they are associated with each other in 
the context of the network. Network analysis will enable 
researchers to develop a more holistic view of cell signal-
ing patterns and their interactions [12].
At present, it is important to introduce two conceptu-
ally different approaches to derive biological meaning from 
molecular profiles. Therefore, consider a gene expression 
profile from cancer cells treated with a ligand (e.g., vascu-
lar endothelial growth factor). The gene expression pro-
file can be regarded as a functional read-out from a set of 
pathways that are activated upon ligand-receptor inter-
action and that culminate in the activation of transcrip-
tion factors, which cause expression changes. Methods to 
reveal these upstream signaling pathways based on expres-
sion changes exist and are henceforth termed “bottom-up” 
approaches. In turn, expression changes will endorse a 
biological response, for example the induction of angio-
genesis. Methods to translate gene expression changes, or 
any other molecular profile, into downstream biological 
responses are henceforth termed “top-down” approaches.
The top-down approach is essentially initiated on the 
identified molecular profile (e.g., the expression pro-
file identified in the imaginary experiment described 
above). The list of genes then goes through a sequence 
of (1) network inference, (2) network topology analysis, 
(3) pathway identification through GSEA, and (4) path-
way prioritization using network and pathway statistics 
identified in steps 2 and 3. Pathway mutual exclusiv-
ity and co-occurrence, revealed by evaluating overlaps 
between sets of pathway-specific genes, may provide 
extra guidance during pathway prioritization [13]. In the 
bottom-up approach, the same sequence is used, but the 
genes on which the sequence is initiated represent the 
set of transcription factors identified through target gene 
enrichment analysis, thus the transcription factors that 
drive the molecular profile. Prior to target gene enrich-
ment analysis, gene clustering can assist in finding sets of 
co-regulated genes, and identifying transcription factors 
based on co-regulated target gene expression may lead to 
more biologically meaningful results [14].
With respect to the analysis strategies outlined above, 
four remarks should be made. First, intuitively, the bot-
tom-up approach is better for identifying pathways, 
whereas the top-down approach is more appropriate to 
evaluate biological processes. Nevertheless, the top-down 
approach performs equally well in identifying signal 
transduction pathway activation secondary to the prior 
molecular changes. Therefore, these two approaches 
should not be regarded as mutually exclusive with respect 
to the pathway-process distinction. Second, networks are 
extremely suited for data integration [12]. Therefore, the 
outlined analysis strategies can be used to perform path-
way analysis based on multiple molecular profiles (e.g., 
mutational and expression data). The dynamic properties 
of signaling networks (e.g., feed-back and feed-forward 
loops) can be visualized, for example by incorporating 
gene expression fold-changes during the network analysis 
stage. Similarly, contributions of different cell types to the 
signaling network can be evaluated by supplying meta-
gene expressions that can be regarded as expression con-
tributions of independent cell populations that co-exist 
in a tumor and that can be identified through multidi-
mensional scaling techniques, such as principal compo-
nent analysis. Relevant network interactions can then be 
analyzed using hidden Markov models or conditional 
random field models [15]. Third, although the bottom-
up approach can be applied to all molecular profiles, the 
description provided in the previous paragraph is only 
truly applicable to transcriptional profiles, due to the 
integration of the target gene enrichment analysis step. 
Last, deciphering tumor biology from molecular profiles 
critically depends on the quality of the tissue sampling 
procedure. From this perspective, the “garbage in, gar-
bage out” computer science principle, which refers to the 
fact that computers will process unintended input data to 
produce nonsensical output, is also applicable in this set-
ting. Several technical aspects that may have deleterious 
effects on data quality should be considered, including 
ischemia and fixation time, used fixatives, and potential 
sampling bias. No matter how sophisticated the analysis 
pipeline is, such quality issues cannot be resolved. Thus, 
researchers who are developing cancer profiling stud-
ies should focus primarily on establishing a rigid tissue 
sampling protocol. In addition, the tissue sampling pro-
tocol could also take into account tumor heterogeneity, 
thus providing multiple samples from the same tumor for 
molecular analysis. This may enable researchers to ana-
lyze in detail the different biological processes and sig-
nal transduction mechanisms operational in one tumor 
sample; this may also enable them to understand how the 
integration of these signals drives tumor biology, such as 
metastatic progression and therapy resistance.
Finally, the outlined analysis strategy does not rep-
resent a novel algorithm. Rather, it presents an analysis 
philosophy that builds on already existing tools, most of 
which are freely accessible online, such as BioConductor 
and R packages, Cytoscape plugins, and Java tools like 
Expression2Kinases [14].
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